Conference on Translational Medicine in Autoimmunity

自身免疫转化医学会议

• 批准号: 6887155
• 负责人: LLOYD H KASPER
• 金额: $ 2万
• 依托单位: KEYSTONE SYMPOSIA
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-01 至 2005-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6887155
• 关键词: autoimmune disorder; autoimmunity; diabetes mellitus; immunopathology therapy; inflammatory bowel diseases; meeting /conference /symposium; multiple sclerosis; rheumatoid arthritis; travel

DESCRIPTION (provided by applicant): Recent advances in the understanding of basic mechanisms of autoimmune disease have led to the development of reagents that can potentially interfere with the disease process and limit disease progression. Although immune mediated therapeutics have already been proven effective for selected autoimmune conditions there are recent developments in clinical immunology that will lead to new approaches for the treatment of autoimmune disease. The implementation of these novel agents into treating human disease is expanding. It is essential that clinical and basic scientists become familiar with these novel approaches for the treatment of these refractory conditions. This meeting will focus on the mechanism and utilization of these therapeutics for the treatment and management of several autoimmune diseases including multiple sclerosis, inflammatory bowel disease, diabetes, systemic lupus and rheumatoid arthritis. The primary emphasis for the sessions will be to provide the audience with information to better appreciate the state of the art and its translation to bedside medicine. To this end, the prime target audience for this meeting will be clinical physicians, translational research scientists, post-doctoral fellows and graduate students interested in gathering more knowledge of the current investigational activities in the field. This meeting represents an important new direction for the Keystone Symposia. It is responsive to the recently formulated "NIH Roadmap" that has targeted translational medicine as a key roadway of this map. The historic association of the Keystone Symposia with frontiers in immunology will allow us to bring in both basic and clinical scientists to this new forum.

描述（由申请人提供）：了解自身免疫性疾病基本机制的最新进展导致了可能干扰疾病过程并限制疾病进展的试剂的发展。尽管免疫介导的治疗剂已被证明对选定的自身免疫性疾病有效，但临床免疫学的最新发展将导致治疗自身免疫性疾病的新方法。这些新型药物治疗人类疾病的实施正在扩大。临床和基础科学家必须熟悉这些新方法来治疗这些难治性疾病，这一点至关重要。这次会议将重点介绍这些治疗剂的机制和利用，用于治疗和管理多种自身免疫性疾病，包括多发性硬化症，炎症性肠病，糖尿病，全身性狼疮和类风湿关节炎。会议的主要重点是为观众提供信息，以更好地欣赏最新技术的状态及其翻译成床边药物。为此，这次会议的主要目标受众将是临床医师，翻译研究科学家，博士后研究员和有兴趣了解该领域当前研究活动的知识的研究生。这次会议代表了基石研讨会的重要新方向。它对最近制定的“ NIH路线图”的响应敏感，该“ NIH路线图”将转化医学作为该地图的重要道路。 Keystone研讨会与免疫学领域的历史性协会将使我们能够引入基本和临床科学家进入这个新论坛。